Literature DB >> 12821498

In vitro antimicrobial susceptibility of Brachyspira pilosicoli isolates from humans.

C J Brooke1, D J Hampson, T V Riley.   

Abstract

The in vitro antimicrobial susceptibility of the anaerobic intestinal spirochete Brachyspira pilosicoli was investigated by an agar dilution method. Human (n = 123) and porcine (n = 16) isolates were susceptible to metronidazole, ceftriaxone, meropenem, tetracycline, moxifloxacin, and chloramphenicol; erythromycin and ciprofloxacin were not active. Resistance to amoxicillin and clindamycin varied. Amoxicillin susceptibility was restored by clavulanic acid.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12821498      PMCID： PMC161862          DOI： 10.1128/AAC.47.7.2354-2357.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  22 in total

1.  Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens.

Authors:  E J Goldstein; D M Citron; C V Merriam; Y Warren; K Tyrrell
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

2.  beta-Lactamase production by intestinal spirochaetes.

Authors:  D S Tompkins; M R Millar; J Heritage; A P West
Journal:  J Gen Microbiol       Date:  1987-03

3.  Otitis media in Australian Aboriginal children: an overview.

Authors:  A J Leach
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1999-10-05       Impact factor: 1.675

4.  Human intestinal spirochaetosis.

Authors:  V Crucioli; A Busuttil
Journal:  Scand J Gastroenterol Suppl       Date:  1981

5.  Carriage of intestinal spirochaetes by humans: epidemiological data from Western Australia.

Authors:  C J Brook; A N Clair; A S Mikosza; T V Riley; D J Hampson
Journal:  Epidemiol Infect       Date:  2001-10       Impact factor: 2.451

6.  Comparative prevalences of Brachyspira aalborgi and Brachyspira (Serpulina) pilosicoli as etiologic agents of histologically identified intestinal spirochetosis in Australia.

Authors:  A S Mikosza; T La; W B de Boer; D J Hampson
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

7.  Intestinal spirochaetosis.

Authors:  W A Harland; F D Lee
Journal:  Br Med J       Date:  1967-09-16

8.  Brachyspira (Serpulina) pilosicoli spirochetemia in an immunocompromised patient.

Authors:  S Kanavaki; E Mantadakis; N Thomakos; A Pefanis; P Matsiota-Bernard; S Karabela; G Samonis
Journal:  Infection       Date:  2002-06       Impact factor: 3.553

9.  Invasive colitis and hepatitis due to previously uncharacterized spirochetes in patients with advanced human immunodeficiency virus infection.

Authors:  J R Kostman; M Patel; E Catalano; J Camacho; J Hoffpauir; M J DiNubile
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

10.  Intestinal spirochaetes in a Gulf Arab population.

Authors:  S P Barrett
Journal:  Epidemiol Infect       Date:  1990-04       Impact factor: 2.451
View more
  10 in total

1.  Bloodstream infection due to Brachyspira pilosicoli in a patient with multiorgan failure.

Authors:  Núria Prim; Roser Pericas; Montse Español; Alba Rivera; Beatriz Mirelis; Pere Coll
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

2.  Genetic and biochemical characterization of FUS-1 (OXA-85), a narrow-spectrum class D beta-lactamase from Fusobacterium nucleatum subsp. polymorphum.

Authors:  Christine Voha; Jean-Denis Docquier; Gian Maria Rossolini; Thierry Fosse
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 3.  The Spirochete Brachyspira pilosicoli, Enteric Pathogen of Animals and Humans.

Authors:  David J Hampson
Journal:  Clin Microbiol Rev       Date:  2017-11-29       Impact factor: 26.132

4.  Answer to February 2021 Photo Quiz.

Authors:  Laura J Gilbert; Benjamin J Rosen; Roseanne A Ressner
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

5.  Penicillin-binding proteins in the pathogenic intestinal spirochete Brachyspira pilosicoli.

Authors:  Rohana P Dassanayake; Gautam Sarath; Gerald E Duhamel
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 6.  Human intestinal spirochetosis--a review.

Authors:  Efstathia Tsinganou; Jan-Olaf Gebbers
Journal:  Ger Med Sci       Date:  2010-01-07

7.  Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.

Authors:  Djalal Meziane-Cherif; Thierry Lambert; Marine Dupêchez; Patrice Courvalin; Marc Galimand
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

8.  Distribution of Flumequine in Intestinal Contents and Colon Tissue in Pigs after Its Therapeutic Use in the Drinking Water.

Authors:  Jose M Rodríguez; M Jose Diez; Matilde Sierra; Juan J Garcia; Nelida Fernandez; Raquel Diez; Ana M Sahagun
Journal:  Animals (Basel)       Date:  2021-05-23       Impact factor: 2.752

Review 9.  Intestinal spirochetosis mimicking inflammatory bowel disease in children.

Authors:  Rossana Helbling; Maria-Chiara Osterheld; Bernard Vaudaux; Katia Jaton; Andreas Nydegger
Journal:  BMC Pediatr       Date:  2012-10-16       Impact factor: 2.125

Review 10.  Brachyspira pilosicoli bloodstream infections: case report and review of the literature.

Authors:  Lilia Bait-Merabet; Arnaud Thille; Patrick Legrand; Christian Brun-Buisson; Vincent Cattoir
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-09-25       Impact factor: 3.944
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.